Adrenocortical carcinoma laboratory findings
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2] Mohammed Abdelwahed M.D[3]
Overview
Overview
Patients with functional adrenocortical carcinoma may have elevated concentrations of serum cortisol, aldosterone, testosterone or estrogen and reduced concentration of plasma renin and potassium.
Laboratory Findings
Laboratory Findings
Laboratory findings consistent with adrenocortical carcinoma are:
| Hormonal disturbance | labs |
|---|---|
| Cortisol[1] |
|
| Steroids[2] |
|
| Epinephrine[3] |
|
| Aldosterone[4] |
|
References
References
- ↑ Dunlap NE, Grizzle WE, Siegel AL (1985). “Cushing’s syndrome. Screening methods in hospitalized patients”. Arch Pathol Lab Med. 109 (3): 222–9. PMID 3838451.
- ↑ Fassnacht M, Allolio B (2009). “Clinical management of adrenocortical carcinoma”. Best Pract Res Clin Endocrinol Metab. 23 (2): 273–89. doi:10.1016/j.beem.2008.10.008. PMID 19500769.
- ↑ Song G, Joe BN, Yeh BM, Meng MV, Westphalen AC, Coakley FV (2011). “Risk of catecholamine crisis in patients undergoing resection of unsuspected pheochromocytoma”. Int Braz J Urol. 37 (1): 35–40, discussion 40-1. PMID 21385478.
- ↑ Arlt W, Biehl M, Taylor AE, Hahner S, Libé R, Hughes BA; et al. (2011). “Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors”. J Clin Endocrinol Metab. 96 (12): 3775–84. doi:10.1210/jc.2011-1565. PMC 3232629. PMID 21917861.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
